BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB
147 results:

  • 1. Multiple factors influence decision making for the surgical treatment in patients with renal cell carcinoma.
    Kröger Dahlin BI; Hlodan J; Ghaffarpour R; Ljungberg B
    Scand J Urol; 2024 Feb; 59():26-30. PubMed ID: 38358280
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. An Updated Systematic Review and Meta-Analysis on the Technical, Oncologic, and Safety Outcomes of Microwave Ablation in Patients with Renal Cell Carcinoma.
    Wu J; Sami S; Lajkosz K; Kishibe T; Ordon M
    J Endourol; 2023 Dec; 37(12):1314-1330. PubMed ID: 37819699
    [No Abstract]    [Full Text] [Related]  

  • 3. Real-world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST-NIVO study): 36-month follow-up results of a clinical chart review.
    Yonese J; Hinata N; Masui S; Nakai Y; Shirotake S; Takeuchi A; Inamoto T; Nozawa M; Ueda K; Etsunaga T; Osawa T; Uemura M; Kimura G; Numakura K; Yamana K; Miyake H; Fukasawa S; Morishima N; Ito H; Uemura H
    Int J Urol; 2023 Sep; 30(9):762-771. PubMed ID: 37248753
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cumulative sum analysis (CUSUM) for evaluating learning curve (LC) of robotic-assisted laparoscopic partial nephrectomy (RALPN).
    Al-Nader M; Radtke JP; Püllen L; Darr C; Kesch C; Hess J; Krafft U; Hadaschik BA; Harke N; Mahmoud O
    J Robot Surg; 2023 Oct; 17(5):2089-2098. PubMed ID: 37213028
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A prospective cohort study of infertility and cancer incidence.
    Wang S; Gaskins AJ; Farland LV; Zhang D; Birmann BM; Rich-Edwards JW; Wang YX; Tamimi RM; Missmer SA; Chavarro JE
    Fertil Steril; 2023 Jul; 120(1):134-142. PubMed ID: 36849034
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Small Bowel Lipomatosis: An Unusual Radiological Finding in Patients With Renal Cell Cancer on Pazopanib.
    Sharma A; Lakhani A; Ghosh-Ray S; Alam S; Padhani A; Gogbashian A; Nathan P
    Anticancer Res; 2023 Feb; 43(2):789-793. PubMed ID: 36697087
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Alcoholic liver disease in relation to cancer incidence and mortality: Findings from a large, matched cohort study in South Korea.
    Tran TPT; Han M; Luu NM; Oh JK
    Cancer Med; 2023 Apr; 12(7):8754-8766. PubMed ID: 36653955
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Biodistribution and dosimetry for combined [
    Delker A; Schleske M; Liubchenko G; Berg I; Zacherl MJ; Brendel M; Gildehaus FJ; Rumiantcev M; Resch S; Hürkamp K; Wenter V; Unterrainer LM; Bartenstein P; Ziegler SI; Beyer L; Böning G
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1280-1290. PubMed ID: 36629878
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The prognostic impact of lymph node dissection for clinically node-negative upper urinary tract urothelial carcinoma in patients who are treated with radical nephroureterectomy.
    Hsieh HC; Wang CL; Chen CS; Yang CK; Li JR; Wang SS; Cheng CL; Lin CY; Chiu KY
    PLoS One; 2022; 17(12):e0278038. PubMed ID: 36454803
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prevalence and risk estimation of cancer-predisposing genes for upper urinary tract urothelial carcinoma in Japanese.
    Sekine Y; Iwasaki Y; Hakozaki N; Endo M; Kamatani Y; Matsuda K; Murakami Y; Sano T; Akamatsu S; Kobayashi T; Nakagawa H; Numakura K; Narita S; Habuchi T; Momozawa Y
    Jpn J Clin Oncol; 2022 Dec; 52(12):1441-1445. PubMed ID: 36093724
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Phosphoproteomic Analysis of FLCN Inactivation Highlights Differential Kinase Pathways and Regulatory TFEB Phosphoserines.
    Glykofridis IE; Henneman AA; Balk JA; Goeij-de Haas R; Westland D; Piersma SR; Knol JC; Pham TV; Boekhout M; Zwartkruis FJT; Wolthuis RMF; Jimenez CR
    Mol Cell Proteomics; 2022 Sep; 21(9):100263. PubMed ID: 35863698
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial.
    Motzer RJ; Powles T; Burotto M; Escudier B; Bourlon MT; Shah AY; Suárez C; Hamzaj A; Porta C; Hocking CM; Kessler ER; Gurney H; Tomita Y; Bedke J; Zhang J; Simsek B; Scheffold C; Apolo AB; Choueiri TK
    Lancet Oncol; 2022 Jul; 23(7):888-898. PubMed ID: 35688173
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Impact of MET status on treatment outcomes in papillary renal cell carcinoma: A pooled analysis of historical data.
    Albiges L; Heng DYC; Lee JL; Walker S; Mellemgaard A; Ottesen L; Frigault MM; L'Hernault A; Wessen J; Choueiri T; Cancel M; Signoretti S
    Eur J Cancer; 2022 Jul; 170():158-168. PubMed ID: 35640484
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A Prospective, Randomized Trial Comparing the Outcomes of Open vs Laparoscopic Partial Nephrectomy.
    Guglielmetti GB; Dos Anjos GC; Sawczyn G; Rodrigues G; Cardili L; Cordeiro MD; Neves LCO; Pontes Junior J; Fazoli A; Coelho RF; Srougi M; Nahas WC
    J Urol; 2022 Aug; 208(2):259-267. PubMed ID: 35404109
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comparison of open versus minimally invasive surgery in the treatment of thoracolumbar metastases.
    Ntilikina Y; Collinet A; Tigan LV; Fabacher T; Steib JP; Charles YP
    Orthop Traumatol Surg Res; 2022 Jun; 108(4):103274. PubMed ID: 35331924
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Role of Renin-Angiotensin System Blockers on BCG Response in Nonmuscle Invasive, High Risk Bladder Cancer.
    Motterle G; Morlacco A; Giovannini G; Vecchiato E; Iafrate M; Calpista A; Prayer-Galetti T; Martino F; Dal Moro F; Novara G
    Clin Genitourin Cancer; 2022 Aug; 20(4):e303-e309. PubMed ID: 35314138
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Single- versus multi-port robotic partial nephrectomy: a comparative analysis of perioperative outcomes and analgesic requirements.
    Glaser ZA; Burns ZR; Fang AM; Saidian A; Magi-Galluzzi C; Nix JW; Rais-Bahrami S
    J Robot Surg; 2022 Jun; 16(3):695-703. PubMed ID: 34406630
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up.
    Barth DA; Sareban N; Lindner AK; Daller LAJ; Matzhold EM; Hutterer G; Smolle M; Mischinger J; Riedl JM; Seles M; Mannweiler S; Bauernhofer T; Pummer K; Pichler R; Zigeuner R; Schlenke P; Pichler M
    Urol Oncol; 2021 Oct; 39(10):736.e9-736.e16. PubMed ID: 34247906
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Single-Port robot assisted partial nephrectomy: initial experience and technique with the da Vinci Single-Port platform (IDEAL Phase 1).
    Francavilla S; Abern MR; Dobbs RW; Vigneswaran HT; Talamini S; Antonelli A; Simeone C; Crivellaro S
    Minerva Urol Nephrol; 2022 Apr; 74(2):216-224. PubMed ID: 33769009
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Testicular ultrasound underestimates the size of small testicular masses: a radiologic-pathologic correlation study.
    Schwen ZR; Liu JL; Gabrielson AT; Patel HD; Gupta M; Rowe SP; Herati AS; Pierorazio PM
    World J Urol; 2021 Sep; 39(9):3399-3405. PubMed ID: 33710425
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.